![]() However, a consensus statement on the evaluation and treatment of nocturia stated that most patients with nocturia do not have OAB, and conversely, most patients with OAB do have nocturia.6 Nocturia is not just a symptom of underlying disease or condition but it itself is a disease with underlying pathophysiology which is clearly understood now. Obstruction (BPO) and is confused with LUTS. We thus propose that it may be necessary to evaluate and treat nocturia as a separate condition, rather than just as a bothersome symptom of another disease. Evaluation of nocturia involves identifying these pathologies. Though there are several contributors to the development of nocturia, these converge into only four distinct pathologies. Nocturia is often considered as symptom of overactive bladder (OAB) or benign prostatic obstruction (BPO) and is confused with LUTS. Pathophysiology and Clinical Evaluation of Nocturia Hence, there is a need to collect epidemiological data and planĬomprehensive studies to evaluate the management strategies for nocturia Theĭata on treatment options used in Indian settings is also very limited. Understood as a common LUTS and a bothersome problem of elderly. Prevalence of nocturia and its impact in Indian populations, but it is Higher prevalence in this population.5 There is no data available on the Output that is produced at night is higher, which could explain the Voids per night.3 In older adults, the proportion of total daily urine Higher with increasing age, and up to 60% of elderly people report ≥2 Prevalence is greater in men than women.4 The prevalence of nocturia is Men and women aged 50-59 years, and after 60 years of age, the ![]() Of nocturia are lower among younger adults.3 Nocturia occurs in 50% of The prevalence of nocturia in community-based populations wasĮvaluated in a review by Bosch and Weiss (Figure 1).3 Prevalence rates (both lifestyle management and pharmacological management) along with aĬoncept for a nocturia clinic, are discussed. Impact of nocturia, and why it may be necessary to consider nocturia asĪ disease rather than a symptom. (ICS) as 'waking at night to void, with each void preceded and followedīy sleep'.2 It is often perceived as a symptom of underlying disease Symptoms (LUTS).1 It is defined by the International Continence Society Women and is one of the most bothersome of the lower urinary tract Nocturia is a common condition that affects both men and Therefore nocturia though perceived as a symptom of many disorders it itself has a defined pathophysiology and needs treatment. Underreported and undertreated status of nocturia, and bring relief to This set-up may help bring about a positive change in the We present the novel concept of a "nocturia clinic", which is aĬomprehensive diagnostic and management center for patients with Pathophysiology and impact of nocturia, as well as the treatment of This review covers the various aspects of With lower urinary tract symptoms, benign prostatic hypertrophy or Combining desmopressin with otherĪgents provides an effective treatment option for nocturia in patients Various pharmacological agentsĪre available, of which desmopressin is considered safe and effective inīoth short- and long-term studies for the treatment of nocturia in menĪnd women, including the elderly. Nocturia with impaired quality of life, cardiovascular morbidity andĪll-cause mortality is well established. Reduced bladder capacity, and sleep disorders). Pathophysiologic mechanisms (24-hour polyuria, nocturnal polyuria, Pathophysiology of nocturia is now well-understood, and it is consideredĪs a disease itself. Often perceived as a symptom of an organic disease, but the On patient's health, quality of life, and economic condition. Waking at night to void is known as nocturia and it is aĬommon condition experienced by both men and women with profound impact
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |